← All stocks

Relay Therapeutics, Inc.

RLAY Net selling

CIK 0001812364 #1471 in the set updated 17 Sep 2026

Bought (120 mo)

$2.20M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$387.85M

$9.98M on a plan · $24.88M straight out of an exercise

Sold at will

$352.99M

161 of 266 sales

Net

−$385.65M

−$350.79M against sales at will

By person

15 insiders · 272 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Third Rock Ventures III, L.P. entity

10% owner

—

$227.13M (12)

−$227.13M

7,739,918

3.53%

$146.59M

+1,274%

SVF Pauling (Cayman) Ltd entity

10% owner

—

$116.40M (1)

−$116.40M

21,904,963

10.00%

$414.88M

—

Patel Sanjiv

President and CEO

$500.00K (1)

$15.86M (37) scheduled

−$15.36M

1,605,951

0.7328%

$30.42M

+4.6%

Bergstrom Donald A

President, R&D

—

$12.10M (62) scheduled

−$12.10M

399,130

0.1821%

$7.56M

+2,261%

Catinazzo Thomas

Chief Financial Officer

—

$10.44M (66) scheduled

−$10.44M

122,851

0.0561%

$2.33M

—

Rahmer Peter

See remarks

—

$3.12M (41) scheduled

−$3.12M

223,657

0.1021%

$4.24M

+1,777%

Adams Brian

Chief Legal Officer

$200.00K (1)

$2.00M (39) scheduled

−$1.80M

371,472

0.1695%

$7.04M

—

INGRAM DOUGLAS S

Director

$500.00K (1)

—

+$500.00K

25,000

0.0114%

$473.50K

—

Rubin Jami

Director

$500.00K (1)

—

+$500.00K

67,242

0.0307%

$1.27M

—

Murcko Mark

Director

$500.00K (1)

$748.75K (1)

−$248.75K

996,952

0.4549%

$18.88M

+128.4%

Porter Andy

Chief Administrative Officer

—

$59.04K (7)

−$59.04K

45,164

0.0206%

$855.41K

+93.0%

Picularium, LLC entity

10% owner

—

3,281,253

1.50%

$62.15M

—

Alexandria Venture Investments, LLC entity

10% owner

—

968,365

0.4419%

$18.34M

—

Borisy Alexis

Director

—

234,175

0.1069%

$4.44M

—

Shawver Laura

Director

—

40,000

0.0183%

$757.60K

−23.2%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Rubin Jami

10 Jun 2024

Director

Exercised, kept

42,242

$5.04

$212.90K

Showing 250 of 272 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 287

Amendments (4/A) skipped 6

Filings about a different issuer 0

Unreadable filings 0

Joint filings 5

Sales on a Rule 10b5-1 plan 48

Sales straight out of an exercise 57

Sales at will 161

Transactions with no price 0

Shares from compensation/vesting 50,611,237

Sales filed before the plan box existed 57

History held since 20 Jul 2020